The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.50
Bid: 103.00
Ask: 108.00
Change: -0.50 (-0.47%)
Spread: 5.00 (4.854%)
Open: 105.50
High: 105.00
Low: 105.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Partnership

14 Nov 2011 07:00

RNS Number : 9875R
Intercede Group PLC
14 November 2011
 



14 November 2011

 

Intercede Group plc ("Intercede")

NEW PARTNERSHIP

Intercede announces MyID now part of HP Assured Identity Plus

Large Scale Identity Programs Targeted

 

Intercede (London Stock Exchange AIM: IGP), the producer of MyID, a world-leader in identity and credential management systems (IDCMS), announces that HP now offers MyID as a component of its Assured Identity Plus solutions. Under the agreement, Intercede and HP will target large scale Federal, state and local government agencies and major enterprise customers.

Intercede's MyID Identity and Credential Management System is a secure and powerful COTS product that sets a new standard for ease of use and integration. MyID is used by 14 US Federal Agencies and is deployed in support of more than 2 million smart cards issued under the Transportation Worker Identity Credential (TWIC) program. Corporate customers include major banks, aerospace and defense contractors and other organizations with high value assets. Around the world, MyID is used for national ID programs and major health care initiatives.

Today, securely managing the identities of employees is a priority for government agencies and major corporations. The Global Identity Practice within the Enterprise Services organization at HP is a proven leader in developing and implementing enterprise-wide and end-to-end identity management solutions. HP Assured Identity Plus offers a more cost effective solution driven by organizational processes based on best-of-breed COTS products like Intercede MyID.

Richard Parris, Chief Executive at Intercede, commented: "I am delighted that Intercede is collaborating with HP to deliver identity management solutions and that MyID is now part of HP's Assured Identity Plus offering. Intercede MyID delivers secure user, card and credential management that is easily configured to meet the specific security needs for logical and physical access. Its recognition by HP is another very significant industry endorsement, and will deliver a wealth of new business opportunities."

"Our clients are looking for proven identity and credential management solutions that satisfy their security requirements," said Todd Musselman, Global Identity Practice Lead, U.S. Public Sector, Enterprise Services, HP. "Working with Intercede, our Assured Identity Plus solution will streamline the time required to establish and manage identity while providing self-service functions to employees improving availability."

 

 

 

 

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

FinnCap

Tel. +44 (0)20 7600 1658

Charles Cunningham

Rose Herbert

Joanna Weaving

Pelham Bell Pottinger

Tel. +44 (0)20 7861 3112

Archie Berens

Clare Gilbey

 

 

 

About Intercede

Intercede is the producer of the MyID Identity and Credential Management System (IDCMS).

Intercede MyID technology is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 14 federal agencies, two million smart cards in support of the US Transportation Worker Identity Credential program (TWIC), four US financial institutions and 320,000 smart corporate identity badges for Boeing, Booz Allen Hamilton and Lockheed Martin. In Europe, Australasia and the Middle East, Intercede MyID is being deployed in support of government identity, financial services, health and corporate employee ID security projects.

Intercede MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing secure registration, biometric capture, application vetting and approval through to smart card personalization, issuance and management.

Intercede MyID was the first electronic personalization product to achieve compliance with the US FIPS-201 Personal Identity Verification (PIV) standard and is widely deployed by federal agencies, government contractors and other commercial entities. In particular, it supports the latest standards applicable for all PIV, PIV-Interoperable and PIV-Compatible deployments.

It can issue and manage a wide variety of IDs and credentials, providing customers with a platform that can meet their needs now and in the future. It is a fully supported commercial off-the-shelf product that can be quickly deployed for thousands or millions of users.

For more information visit www.intercede.com

 

HP Assured Identity Plus Overview:

http://h20195.www2.hp.com/V2/GetPDF.aspx/4AA2-8833ENW.pdf

 

Older format:

http://www.hpcollateral.com/Files/EcoCollateral_20100429_4AA2-8833ENW_ohua.pdf

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SALLLFSRLELLLIL
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.